476 related articles for article (PubMed ID: 31847881)
21. The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence.
Tapia Rico G; Chan MM; Loo KF
Cancer Treat Rev; 2020 Jun; 86():102011. PubMed ID: 32213376
[TBL] [Abstract][Full Text] [Related]
22. Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India.
Saravanan S; Velu V; Kumarasamy N; Nandakumar S; Murugavel KG; Balakrishnan P; Suniti S; Thyagarajan SP
World J Gastroenterol; 2007 Oct; 13(37):5015-20. PubMed ID: 17854146
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection.
Norris S; Taylor C; Muiesan P; Portmann BC; Knisely AS; Bowles M; Rela M; Heaton N; O'Grady JG
Liver Transpl; 2004 Oct; 10(10):1271-8. PubMed ID: 15376307
[TBL] [Abstract][Full Text] [Related]
24. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
[TBL] [Abstract][Full Text] [Related]
25. Haemophagocytic lymphohistiocytosis in patients treated with immune checkpoint inhibitors: analysis of WHO global database of individual case safety reports.
Noseda R; Bertoli R; Müller L; Ceschi A
J Immunother Cancer; 2019 May; 7(1):117. PubMed ID: 31046841
[TBL] [Abstract][Full Text] [Related]
26. Safety of Immune Checkpoint Inhibitors in Patients with Cancer and Hepatitis C Virus Infection.
Alkrekshi A; Tamaskar I
Oncologist; 2021 May; 26(5):e827-e830. PubMed ID: 33655663
[TBL] [Abstract][Full Text] [Related]
27. Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infection.
Tio M; Rai R; Ezeoke OM; McQuade JL; Zimmer L; Khoo C; Park JJ; Spain L; Turajlic S; Ardolino L; Yip D; Goldinger SM; Cohen JV; Millward M; Atkinson V; Kane AY; Ascierto PA; Garbe C; Gutzmer R; Johnson DB; Rizvi HA; Joshua AM; Hellmann MD; Long GV; Menzies AM
Eur J Cancer; 2018 Nov; 104():137-144. PubMed ID: 30347289
[TBL] [Abstract][Full Text] [Related]
28. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
[TBL] [Abstract][Full Text] [Related]
29. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
30. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
Al-Mughales JA
J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
Chen M; Wong WW; Law MG; Kiertiburanakul S; Yunihastuti E; Merati TP; Lim PL; Chaiwarith R; Phanuphak P; Lee MP; Kumarasamy N; Saphonn V; Ditangco R; Sim BL; Nguyen KV; Pujari S; Kamarulzaman A; Zhang F; Pham TT; Choi JY; Oka S; Kantipong P; Mustafa M; Ratanasuwan W; Durier N; Chen YM
PLoS One; 2016; 11(3):e0150512. PubMed ID: 26933963
[TBL] [Abstract][Full Text] [Related]
32. Short and Long-Term Postoperative Complications Following Total Joint Arthroplasty in Patients With Human Immunodeficiency Virus, Hepatitis B, or Hepatitis C.
Kildow BJ; Politzer CS; DiLallo M; Bolognesi MP; Seyler TM
J Arthroplasty; 2018 Jul; 33(7S):S86-S92.e1. PubMed ID: 29198873
[TBL] [Abstract][Full Text] [Related]
33. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
[TBL] [Abstract][Full Text] [Related]
34. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system.
Zhai Y; Ye X; Hu F; Xu J; Guo X; Zhuang Y; He J
J Immunother Cancer; 2019 Nov; 7(1):286. PubMed ID: 31694698
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.
Phuangchoei P; Chotiyaputta W; Chayakulkeeree M
J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291
[TBL] [Abstract][Full Text] [Related]
36. [Investigation of occult hepatitis B in HIV infected patients].
Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
[TBL] [Abstract][Full Text] [Related]
37. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.
Nardo M; Yilmaz B; Nelson BE; Torres HA; Wang LS; Granwehr BP; Song J; Dalla Pria HRF; Trinh VA; Glitza Oliva IC; Patel SP; Tannir NM; Kaseb AO; Altan M; Lee SS; Miller E; Zhang H; Stephen BA; Naing A
Oncologist; 2023 Aug; 28(8):714-721. PubMed ID: 36952233
[TBL] [Abstract][Full Text] [Related]
38. Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.
Sirinak C; Kittikraisak W; Pinjeesekikul D; Charusuntonsri P; Luanloed P; Srisuwanvilai LO; Nateniyom S; Akksilp S; Likanonsakul S; Sattayawuthipong W; Burapat C; Varma JK
BMC Public Health; 2008 Jul; 8():245. PubMed ID: 18638392
[TBL] [Abstract][Full Text] [Related]
39. High prevalence of syphilis, HBV, and HCV co-infection, and low rate of effective vaccination against hepatitis B in HIV-infected patients in West China hospital.
Yang T; Chen Q; Li D; Wang T; Gou Y; Wei B; Tao C
J Med Virol; 2018 Jan; 90(1):101-108. PubMed ID: 28792076
[TBL] [Abstract][Full Text] [Related]
40. Multiple viral infections in a group of intravenous drug users: hepatitis B virus exposure is the risk factor.
Santolamazza M; Delle Monache M; Alvino A; Bacosi M; D'Innocenzo S; Ciervo U; Antonaci A; Russo F; Miglioresi L; De Angelis A; Ursitti A; Ricci GL
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1347-54. PubMed ID: 11692062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
